Federal Act
on Medically Assisted Reproduction
(Reproductive Medicine Act, RMA)

¹ The ana­lys­is of the ge­net­ic ma­ter­i­al of re­pro­duct­ive cells and their se­lec­tion to in­flu­ence the sex or oth­er char­ac­ter­ist­ics of the child are only per­mit­ted in or­der to identi­fy chro­mo­somal prop­er­ties that may in­hib­it the de­vel­op­ment ca­pa­city of the em­bryo to be cre­ated, or if there is no oth­er way of avoid­ing the risk of trans­mit­ting a pre­dis­pos­i­tion for a ser­i­ous dis­ease. Art­icle 22 para­graph 4 is re­served.

² The ana­lys­is of the ge­net­ic ma­ter­i­al of em­bry­os in vitro and their se­lec­tion ac­cord­ing to sex or ac­cord­ing to oth­er char­ac­ter­ist­ics are only per­mit­ted if:

a.

there is no oth­er way of avoid­ing the risk of an em­bryo with a hered­it­ary pre­dis­pos­i­tion for a ser­i­ous dis­ease from im­plant­ing in the uter­us;

b.

it is prob­able that the ser­i­ous dis­ease will oc­cur be­fore the age of 50;

c.

no ef­fect­ive or ex­pedi­ent ther­apy is avail­able for com­bat­ing the ser­i­ous dis­ease; and

d.

the couple have in­formed the phys­i­cian in writ­ing that they are not pre­pared to ac­cept the risk in terms of let­ter a.

³ They are also per­mit­ted in or­der to identi­fy chro­mo­somal prop­er­ties that may in­hib­it the de­vel­op­ment ca­pa­city of the em­bryo.